A plaintiff, Larry W., files a products liability lawsuit against DePuy Orthopedics, Inc., alleging he suffered from severe adverse effects and complications from the manufacturers ASR hip implant product.

According to the DePuy ASR hip implant defects lawsuit, Larry was allegedly implanted with the DePuy ASR hip implant product in January 2009 at Sumner Regional Medical Center.

However, soon after the implantation, although not quite sure of when exactly thereafter it first began, the plaintiff says he suffered pain, and that pain and injury was “ongoing and continuing in nature.”

Larry claims that he later had to have the DePuy ASR hip implant explanted in February 2017. He had the implant removed at St. Thomas Hospital West in Nashville, Tenn.

He states that he “could not have known that the injuries he suffered were as a result of a defect in the ASR hip implant until after the date the device was recalled from the market and [he] came to learn of the recall.”

Purportedly, he had not known that he suffered injuries from increased amounts of chromium and cobalt within her bloodstream (metallosis) until he had blood drawn and was advised of the blood-work composite.

The claims and allegations filed by the plaintiff against the defendant include, but are not limited to, the following: Negligence, Strict Products Liability- Defective Design, Strict Products Liability- Manufacturing Defect, Strict Products Liability-Failure to Warn, Breach of Express Warranty, and Breach of Implied Warranties.

DePuy ASR Hip Implant Defects Lawsuit Facts

In the years following the DePuy ASR hip implant defect recall, several patients are hoping to reach DePuy ASR hip implant settlements.

According to these DePuy ASR hip implant defects lawsuits, these patients who have been inserted with a prosthetic hip implant from DePuy, like Larry, later suffered severe adverse effects and complications. They seek to become compensated for the injuries suffered, including lost wages and medical expenses.

In 2010, the U.S. Food and Drug Administration (FDA) first issued a recall of the DePuy ASR hip implant device. The recall allegedly included 93,000 hip implant devices. A third of this amount, roughly 37,000, included patients that had been implanted with this device who are residents of the United States.

The ASR recall was announced due to the specific adverse effects and complications suffered and reported. In a study conducted in the U.K., it was found that 13% of patients who were implanted with the DePuy ASR hip implant device had to undergo revision surgery.

The adverse effects that led to the recall in 2010 include metallosis, the medical condition involving the deposition and build-up of metal debris in the soft tissues of the body. Other adverse effects may include cobalt poisoning, loss of bone strength or structure, the development of pseudotumors that develop around the hip implant, and cancer.

The DePuy ASR Hip Implant Defects Lawsuit is Case No. 1:17-dp-20059-JJH, in the U.S. District Court for the Northern District of Ohio. The DePuy MDL is No. 1:10 md 2197, In Re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation, in the U.S. District Court for the Northern District of Ohio, Western Division.